Edition:
United States

Acrux Ltd (ACR.AX)

ACR.AX on Australia Stock Exchange

0.25AUD
22 May 2017
Change (% chg)

-- (--)
Prev Close
$0.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
397,649
52-wk High
$0.83
52-wk Low
$0.25

Latest Key Developments (Source: Significant Developments)

Acrux says U.S. Patent and Trademark Office institutes IPR proceeding against a U.S. Patent
Monday, 1 May 2017 09:14pm EDT 

May 2 (Reuters) - Acrux Ltd :U.S. Patent and Trademark Office has instituted an inter partes review (IPR) proceeding filed by Acrux against U.S. Patent no. 7,214,506.Patent relates to methods of using various antifungal compounds, including efinaconazole, for treatment of onychomycosis.U.S. Patent No. 7,214,506 is owned by Kaken Pharmaceutical Co Ltd. and licensed to Valeant Pharmaceuticals International Inc.  Full Article

Acrux Ltd reports quarterly global Axiron sales of US$39.9 mln
Tuesday, 31 Jan 2017 05:51pm EST 

Acrux Ltd :Global Axiron net sales of US$39.9 million in its financial results for quarter ending 31 Dec 2016, up from US$39.0 million for previous quarter.  Full Article

Acrux filed new provisional patent application covering its pipeline product acr-065
Tuesday, 1 Nov 2016 08:24pm EDT 

Acrux Ltd : Filed a new provisional patent application covering its pipeline product acr-065 which is targeting fungal infection of nail bed in toes and fingers .Acrux is progressing development and expects to initiate clinical trials in second half of 2017.  Full Article

Acrux filed new provisional patent application covering its pipeline product acr-065
Tuesday, 1 Nov 2016 07:34pm EDT 

Acrux Ltd : Filed a new provisional patent application covering its pipeline product acr-065 which is targeting fungal infection of nail bed in toes and fingers .Acrux is progressing development and expects to initiate clinical trials in second half of 2017.  Full Article

Acrux Ltd appoints Tim Bateman as Chief Financial Officer
Sunday, 9 Oct 2016 10:49pm EDT 

Acrux Ltd : Tim bateman has been appointed to role of Chief Financial Officer and Company Secretary .Tim bateman replaces Sharon Papworth who has resigned from the co..  Full Article

Acrux says will defer release of its financial results for year ended 30 June 2016
Monday, 8 Aug 2016 12:20am EDT 

Acrux Ltd : Will defer release of its financial results for the year ended 30 June 2016 .  Full Article

Acrux provides Axiron patent litigation update
Wednesday, 29 Jun 2016 07:53pm EDT 

Acrux Ltd : Acrux generic strategy and axiron patent litigation update . Conduct of the lawsuit will not have a material impact on Acrux operating expenditure . Formal litigation proceedings began this month in the United States district court for the southern district of Indiana against generic companies .  Full Article

More From Around the Web

BRIEF-Acrux Ltd reports quarterly global Axiron sales of US$39.9 mln

* Global Axiron net sales of US$39.9 million in its financial results for quarter ending 31 Dec 2016, up from US$39.0 million for previous quarter Source text for Eikon: Further company coverage: